导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 8.01% | 330/1050 |
| 近一周 | -2.29% | 527/1104 |
| 近一月 | -2.01% | 225/1102 |
| 近一季 | -6.20% | 473/1092 |
| 近半年 | 2.36% | 375/1070 |
| 近一年 | 12.35% | 324/1018 |
| 近两年 | 97.86% | 200/926 |
| 近三年 | 68.42% | 158/834 |
| 成立以来 | 132.09% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.98% 556/1070 |
23.80% 357/1101 |
- - |
- - |
| 2025 | 40.33% 320/1065 |
5.48% 379/1014 |
9.61% 117/1038 |
19.26% 629/1050 |
1.77% 329/1065 |
| 2024 | 10.34% 280/1011 |
-5.36% 588/960 |
-1.96% 436/983 |
13.52% 345/991 |
4.77% 149/1011 |
| 2023 | 3.14% 59/952 |
7.11% 218/880 |
0.01% 191/895 |
-2.73% 193/915 |
-1.02% 168/952 |
| 2022 | -18.70% 286/867 |
-12.45% 162/773 |
3.34% 616/806 |
-7.79% 132/845 |
-2.55% 561/867 |
| 2021 | 25.82% 107/740 |
1.63% 96/580 |
14.56% 243/659 |
6.33% 99/704 |
1.63% 371/740 |
| 2020 | 29.76% 348/554 |
-1.86% 210/419 |
19.17% 301/466 |
12.25% 198/517 |
-1.16% 495/554 |
| 2019 | - - |
- - |
- - |
- - |
3.93% 364/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 博道伍佰智航股票C VS. 东吴新产业精选股票A(580008) |